Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Lysosomal Alpha Glucosidase Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Lysosomal Alpha Glucosidase Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 AT-982
      • 1.3.3 ATB-200
      • 1.3.4 AVRRD-03
      • 1.3.5 JR-162
      • 1.3.6 MOSS-GAA
      • 1.3.7 OXY-2810
      • 1.3.8 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Lysosomal Alpha Glucosidase Market Share by Application (2019-2025)
      • 1.4.2 Glycogen Storage Disease
      • 1.4.3 Pompe Disease
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Lysosomal Alpha Glucosidase Market Size
      • 2.1.1 Global Lysosomal Alpha Glucosidase Revenue 2014-2025
      • 2.1.2 Global Lysosomal Alpha Glucosidase Sales 2014-2025
    • 2.2 Lysosomal Alpha Glucosidase Growth Rate by Regions
      • 2.2.1 Global Lysosomal Alpha Glucosidase Sales by Regions 2014-2019
      • 2.2.2 Global Lysosomal Alpha Glucosidase Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Lysosomal Alpha Glucosidase Sales by Manufacturers
      • 3.1.1 Lysosomal Alpha Glucosidase Sales by Manufacturers 2014-2019
      • 3.1.2 Lysosomal Alpha Glucosidase Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Lysosomal Alpha Glucosidase Revenue by Manufacturers (2014-2019)
      • 3.2.2 Lysosomal Alpha Glucosidase Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Lysosomal Alpha Glucosidase Market Concentration Ratio (CR5 and HHI)
    • 3.3 Lysosomal Alpha Glucosidase Price by Manufacturers
    • 3.4 Key Manufacturers Lysosomal Alpha Glucosidase Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Lysosomal Alpha Glucosidase Market
    • 3.6 Key Manufacturers Lysosomal Alpha Glucosidase Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 AT-982 Sales and Revenue (2014-2019)
      • 4.1.2 ATB-200 Sales and Revenue (2014-2019)
      • 4.1.3 AVRRD-03 Sales and Revenue (2014-2019)
      • 4.1.4 JR-162 Sales and Revenue (2014-2019)
      • 4.1.5 MOSS-GAA Sales and Revenue (2014-2019)
      • 4.1.6 OXY-2810 Sales and Revenue (2014-2019)
      • 4.1.7 Others Sales and Revenue (2014-2019)
    • 4.2 Global Lysosomal Alpha Glucosidase Sales Market Share by Type
    • 4.3 Global Lysosomal Alpha Glucosidase Revenue Market Share by Type
    • 4.4 Lysosomal Alpha Glucosidase Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Lysosomal Alpha Glucosidase Sales by Application

    6 United States

    • 6.1 United States Lysosomal Alpha Glucosidase Breakdown Data by Company
    • 6.2 United States Lysosomal Alpha Glucosidase Breakdown Data by Type
    • 6.3 United States Lysosomal Alpha Glucosidase Breakdown Data by Application

    7 European Union

    • 7.1 European Union Lysosomal Alpha Glucosidase Breakdown Data by Company
    • 7.2 European Union Lysosomal Alpha Glucosidase Breakdown Data by Type
    • 7.3 European Union Lysosomal Alpha Glucosidase Breakdown Data by Application

    8 China

    • 8.1 China Lysosomal Alpha Glucosidase Breakdown Data by Company
    • 8.2 China Lysosomal Alpha Glucosidase Breakdown Data by Type
    • 8.3 China Lysosomal Alpha Glucosidase Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Lysosomal Alpha Glucosidase Breakdown Data by Company
    • 9.2 Rest of World Lysosomal Alpha Glucosidase Breakdown Data by Type
    • 9.3 Rest of World Lysosomal Alpha Glucosidase Breakdown Data by Application
    • 9.4 Rest of World Lysosomal Alpha Glucosidase Breakdown Data by Countries
      • 9.4.1 Rest of World Lysosomal Alpha Glucosidase Sales by Countries
      • 9.4.2 Rest of World Lysosomal Alpha Glucosidase Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Amicus Therapeutics Inc
      • 10.1.1 Amicus Therapeutics Inc Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Lysosomal Alpha Glucosidase
      • 10.1.4 Lysosomal Alpha Glucosidase Product Introduction
      • 10.1.5 Amicus Therapeutics Inc Recent Development
    • 10.2 Audentes Therapeutics Inc
      • 10.2.1 Audentes Therapeutics Inc Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Lysosomal Alpha Glucosidase
      • 10.2.4 Lysosomal Alpha Glucosidase Product Introduction
      • 10.2.5 Audentes Therapeutics Inc Recent Development
    • 10.3 Etubics Corp
      • 10.3.1 Etubics Corp Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Lysosomal Alpha Glucosidase
      • 10.3.4 Lysosomal Alpha Glucosidase Product Introduction
      • 10.3.5 Etubics Corp Recent Development
    • 10.4 Genzyme Corp
      • 10.4.1 Genzyme Corp Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Lysosomal Alpha Glucosidase
      • 10.4.4 Lysosomal Alpha Glucosidase Product Introduction
      • 10.4.5 Genzyme Corp Recent Development
    • 10.5 greenovation Biotech GmbH
      • 10.5.1 greenovation Biotech GmbH Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Lysosomal Alpha Glucosidase
      • 10.5.4 Lysosomal Alpha Glucosidase Product Introduction
      • 10.5.5 greenovation Biotech GmbH Recent Development
    • 10.6 Huons Co Ltd
      • 10.6.1 Huons Co Ltd Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Lysosomal Alpha Glucosidase
      • 10.6.4 Lysosomal Alpha Glucosidase Product Introduction
      • 10.6.5 Huons Co Ltd Recent Development
    • 10.7 JCR Pharmaceuticals Co Ltd
      • 10.7.1 JCR Pharmaceuticals Co Ltd Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Lysosomal Alpha Glucosidase
      • 10.7.4 Lysosomal Alpha Glucosidase Product Introduction
      • 10.7.5 JCR Pharmaceuticals Co Ltd Recent Development
    • 10.8 Oxyrane Belgium NV
      • 10.8.1 Oxyrane Belgium NV Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Lysosomal Alpha Glucosidase
      • 10.8.4 Lysosomal Alpha Glucosidase Product Introduction
      • 10.8.5 Oxyrane Belgium NV Recent Development
    • 10.9 Pharming Group NV
      • 10.9.1 Pharming Group NV Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Lysosomal Alpha Glucosidase
      • 10.9.4 Lysosomal Alpha Glucosidase Product Introduction
      • 10.9.5 Pharming Group NV Recent Development
    • 10.10 Sarepta Therapeutics Inc
      • 10.10.1 Sarepta Therapeutics Inc Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Lysosomal Alpha Glucosidase
      • 10.10.4 Lysosomal Alpha Glucosidase Product Introduction
      • 10.10.5 Sarepta Therapeutics Inc Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Lysosomal Alpha Glucosidase Sales Channels
      • 11.2.2 Lysosomal Alpha Glucosidase Distributors
    • 11.3 Lysosomal Alpha Glucosidase Customers

    12 Market Forecast

    • 12.1 Global Lysosomal Alpha Glucosidase Sales and Revenue Forecast 2019-2025
    • 12.2 Global Lysosomal Alpha Glucosidase Sales Forecast by Type
    • 12.3 Global Lysosomal Alpha Glucosidase Sales Forecast by Application
    • 12.4 Lysosomal Alpha Glucosidase Forecast by Regions
      • 12.4.1 Global Lysosomal Alpha Glucosidase Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Lysosomal Alpha Glucosidase Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Lysosomal Alpha Glucosidase is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Lysosomal Alpha Glucosidase.

      This report studies the global market size of Lysosomal Alpha Glucosidase, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Lysosomal Alpha Glucosidase sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Amicus Therapeutics Inc
      Audentes Therapeutics Inc
      Etubics Corp
      Genzyme Corp
      greenovation Biotech GmbH
      Huons Co Ltd
      JCR Pharmaceuticals Co Ltd
      Oxyrane Belgium NV
      Pharming Group NV
      Sarepta Therapeutics Inc

      Market Segment by Product Type
      AT-982
      ATB-200
      AVRRD-03
      JR-162
      MOSS-GAA
      OXY-2810
      Others

      Market Segment by Application
      Glycogen Storage Disease
      Pompe Disease
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Lysosomal Alpha Glucosidase status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Lysosomal Alpha Glucosidase manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Lysosomal Alpha Glucosidase are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now